Hutchmed secures priority review in China for ORPATHYS and TAGRISSO combination therapy

Hutchmed (China) Limited has achieved a significant milestone with the acceptance of its New Drug Application (NDA) by China’s National Medical Products Administration (NMPA) for ... Read More